Sagent Pharmaceuticals, Inc. - FORM S-1MEF - EX-23.2 - CONSENT OF ERNST & YOUNG HUA MING, INDEPENDENT AUDITORS - April 19, 2011

Attached files

file filename
EX-23.1 - CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Sagent Pharmaceuticals, Inc.dex231.htm
S-1MEF - S-1MEF - Sagent Pharmaceuticals, Inc.ds1mef.htm
EX-5.1 - OPINION OF KIRKLAND & ELLIS LLP - Sagent Pharmaceuticals, Inc.dex51.htm

Exhibit 23.2

 

Consent of Independent Auditors

 

We consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated February 23, 2011, with respect to the financial statements of Kanghong Sagent (Chengdu) Pharmaceutical Co., Ltd. (a development stage company) included in Amendment No. 5 of the Registration Statement (Form S-1 No. 333-170979) of Sagent Holding Co., filed with the Securities and Exchange Commission.

 

/s/ Ernst & Young Hua Ming

Shanghai, the People’s Republic of China

April 19, 2011

Sagent Pharmaceuticals, Inc. Reports